Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.

Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR.

BJU Int. 2012 Jul;110(1):50-5. doi: 10.1111/j.1464-410X.2011.10704.x. Epub 2011 Nov 11.

2.

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.

Mowatt G, Scotland G, Boachie C, Cruickshank M, Ford JA, Fraser C, Kurban L, Lam TB, Padhani AR, Royle J, Scheenen TW, Tassie E.

Health Technol Assess. 2013 May;17(20):vii-xix, 1-281. doi: 10.3310/hta17200. Review.

3.

Prostate biopsy: who, how and when. An update.

Djavan B, Milani S, Remzi M.

Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Review.

PMID:
15780165
4.

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.

Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS.

Eur Urol. 2013 Feb;63(2):214-30. doi: 10.1016/j.eururo.2012.09.033. Epub 2012 Sep 25. Review.

PMID:
23021971
5.

Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel.

Smeenge M, Barentsz J, Cosgrove D, de la Rosette J, de Reijke T, Eggener S, Frauscher F, Kovacs G, Matin SF, Mischi M, Pinto P, Rastinehad A, Rouviere O, Salomon G, Polascik T, Walz J, Wijkstra H, Marberger M.

BJU Int. 2012 Oct;110(7):942-8. doi: 10.1111/j.1464-410X.2012.11072.x. Epub 2012 Mar 30.

6.

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Bjurlin MA, Carter HB, Schellhammer P, Cookson MS, Gomella LG, Troyer D, Wheeler TM, Schlossberg S, Penson DF, Taneja SS.

J Urol. 2013 Jun;189(6):2039-46. doi: 10.1016/j.juro.2013.02.072. Epub 2013 Feb 26. Review.

7.

Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.

Leone A, Gershman B, Rotker K, Butler C, Fantasia J, Miller A, Afiadata A, Amin A, Zhou A, Jiang Z, Sebo T, Mega A, Schiff S, Pareek G, Golijanin D, Yates J, Karnes RJ, Renzulli J.

Prostate Cancer Prostatic Dis. 2016 Mar;19(1):68-71. doi: 10.1038/pcan.2015.52. Epub 2015 Nov 17. Review.

PMID:
26857145
8.

Random biopsy: when, how many and where to take the cores?

Scattoni V, Maccagnano C, Capitanio U, Gallina A, Briganti A, Montorsi F.

World J Urol. 2014 Aug;32(4):859-69. doi: 10.1007/s00345-014-1335-0. Epub 2014 Jun 8. Review.

PMID:
24908067
9.

[Conventional transrectal ultrasound guided biopsy. Current role, indications, techniques and limitations].

Areal Calama J.

Arch Esp Urol. 2015 Apr;68(3):282-95. Review. Spanish.

PMID:
25948800
10.

Biopsy strategies for selecting patients for focal therapy for prostate cancer.

Kanthabalan A, Emberton M, Ahmed HU.

Curr Opin Urol. 2014 May;24(3):209-17. doi: 10.1097/MOU.0000000000000046. Review.

PMID:
24670871
11.

Systematic extended and saturation prostate biopsy: when and how.

Scattoni V, Maccagnano C, Zanni G, Angiolilli D, Raber M, Rigatti P, Montorsi F.

Minerva Urol Nefrol. 2010 Jun;62(2):179-92. Review.

PMID:
20562798
12.

Transperineal biopsy of the prostate--is this the future?

Chang DT, Challacombe B, Lawrentschuk N.

Nat Rev Urol. 2013 Dec;10(12):690-702. doi: 10.1038/nrurol.2013.195. Epub 2013 Sep 24. Review.

PMID:
24061531
13.

Diagnostic accuracy of prostate needle biopsy.

Donahue T, Moul J.

Curr Urol Rep. 2002 Jun;3(3):215-21. Review.

PMID:
12084191
14.

A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Heijmink SW, van Moerkerk H, Kiemeney LA, Witjes JA, Frauscher F, Barentsz JO.

Eur Radiol. 2006 Apr;16(4):927-38. Epub 2006 Jan 4. Review.

PMID:
16391907
15.

Diagnostic accuracy of transrectal elastosonography (TRES) imaging for the diagnosis of prostate cancer: a systematic review and meta-analysis.

Aboumarzouk OM, Ogston S, Huang Z, Evans A, Melzer A, Stolzenberg JU, Nabi G.

BJU Int. 2012 Nov;110(10):1414-23; discussion 1423. doi: 10.1111/j.1464-410X.2012.11106.x. Epub 2012 Mar 30. Review.

16.

Robotic prostate biopsy and its relevance to focal therapy of prostate cancer.

Ho H, Yuen JS, Cheng CW.

Nat Rev Urol. 2011 Sep 20;8(10):579-85. doi: 10.1038/nrurol.2011.131. Review.

PMID:
21931344
17.

Prostate biopsy in the diagnosis of prostate cancer: current trends and techniques.

Lowe FC, Nagler EA.

Drugs Today (Barc). 2005 Mar;41(3):179-91. Review.

PMID:
15883615
18.

How to improve prostate biopsy detection of prostate cancer.

Ornstein DK, Kang J.

Curr Urol Rep. 2001 Jun;2(3):218-23. Review.

PMID:
12084268
19.

Pathologic basis of focal therapy for early-stage prostate cancer.

Mouraviev V, Mayes JM, Polascik TJ.

Nat Rev Urol. 2009 Apr;6(4):205-15. doi: 10.1038/nrurol.2009.29. Review.

PMID:
19352395
20.

DNA comparison between operative and biopsy specimens to investigate stage pT0 after radical prostatectomy.

Bessede T, Girodon E, Allory Y, Le Floch A, Leroy K, Salomon L.

World J Urol. 2014 Aug;32(4):899-904. doi: 10.1007/s00345-014-1278-5. Epub 2014 Mar 27. Review.

PMID:
24671609

Supplemental Content

Support Center